prame
3 articles tagged with ‘prame’
PRAME Peptide Therapy: A Targeted Approach in Cancer Immunotherapy Research
PRAME is a cancer-testis antigen overexpressed in multiple malignancies, making it a prime target for peptide-based immunotherapy. This article explores PRAME's biological functions, diagnostic utility, and therapeutic strategies, including peptide vaccines and T-cell receptor-engineered T cells. Learn how researchers leverage PRAME peptides for translational studies and clinical immunomonitoring.
Wegovy in Research: Peptide Insights for Cancer and Infection Immunology
Explore how peptide research, including insights from LMP-1, TIL therapy, PRAME, and Influenza A Matrix Protein 1, informs immunology and virus studies. Learn about the role of synthetic peptides in understanding pathogen and tumor biology, and how Volta Peptides supports researchers with tools and guides.
Cancer-Testis Antigens: Targets for Immunotherapy Research
Cancer-Testis Antigens (CTAs) are normally restricted to germline tissues like testis or placenta, which are immune-privileged and lack MHC class I expression. Their aberrant expression in various cancers makes them ideal targets for immunotherapy due to minimal expression in normal somatic tissues. This article focuses on two key CTAs, NY-ESO-1 and PRAME, and their roles in T-cell-based immunotherapy.